Review of CDC Anthrax Lab Incident, Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, U.S. House of Representatives, One Hundred Thirteenth Congress, Second Session, July 16, 2014 [open pdf - 3MB]
This testimony is from the July 16, 2014 hearing, "Review of CDC [Centers for Disease Control and Prevention] Anthrax Lab Incident" before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce. From the opening statement of Tim Murphy: "The subcommittee today examines the CDC anthrax incident last month that potentially exposed dozens of CDC researchers to live anthrax because established safety procedures were not followed. Last Friday, the CDC Director announced the findings of CDC's own internal review of the incident and the corrective actions being taken. CDC's review identified a fundamental flaw: the agency had no written study plan to ensure the safety of its workers and the proper handling of live biological agents, like anthrax. The Department of Agriculture's investigation revealed more disturbing details. During the inspection, CDC workers could not locate some of their anthrax samples. It took more than a week for the inspectors and CDC management to track down the anthrax samples that are in CDC's custody." Statements, letters, and other materials submitted for the record include those of the following: Thomas R. Frieden, Jere Dick, Nancy Kingsbury, Sean G. Kaufman, and Richard H. Ebright.
Serial No. 113-160
U.S. Government Printing Office: http://www.gpo.gov/